Dr. Michael Kinch, Executive Dean for Sciences and Vice President for Innovation, creates and deploys innovative approaches to improve biomedical translation and entrepreneurship. He founded the directed the Center for Research Innovation in Biotechnology (CRIB). As Executive Dean of Sciences at Long Island University, he helped reconsider how academia can contribute to student success in biomedial pre-professional education. As Associate Vice Chancellor at Washington University in St. Louis, he helped lead entrepreneurship activities and founded the Centers for Research Innovation in Biotechnology (CRIB) and Drug Discovery (CDD), which analyzes innovation in the science and business of medicines. At Yale University, he founded and led the Yale Center for Molecular Discovery. Prior to Yale, Dr Kinch held executive positions at MedImmune, and at Functional Genetics, Inc, where he led R&D. He was also on the faculty at Johns Hopkins University and Purdue University. Dr. Kinch has published more than 150 papers and five dozen US patents. He has written multiple books, which convey key trends in the research, development and distribution of medicines and vaccines. His research has been profiled in media outlets such as The Wall Street Journal, The Washington Post, The New York Times, CNN, the BBC and Bloomberg News. Dr Kinch earned a PhD in Immunology from Duke University and a bachelor’s of science in Molecular Genetics from The Ohio State University.